• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌与良性乳腺病变患者的肠道菌群分析。

Analysis of Gut Microbiota in Patients with Breast Cancer and Benign Breast Lesions.

机构信息

Department of Surgical Oncology, The Affiliated Hospital of Qinghai University, Xining, China.

Graduate School of Qinghai University, Xining, China.

出版信息

Pol J Microbiol. 2022 May 31;71(2):217-226. doi: 10.33073/pjm-2022-019.

DOI:10.33073/pjm-2022-019
PMID:35675827
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9252143/
Abstract

Breast cancer (BC) and benign breast lesions (BBLs) are common diseases in women worldwide. The gut microbiota plays a vital role in regulating breast diseases' formation, progression, and therapy response. Hence, we explored the structure and function of gut microflora in patients with BC and BBLs. A cohort of 66 subjects was enrolled in the study. Twenty-six subjects had BC, 20 subjects had BBLs, and 20 matched healthy controls. High throughput 16S ribosomal RNA (16S rRNA) gene sequencing technology was used to determine the microbial community structure. Compared with healthy individuals, BC patients had significantly lower alpha diversity indices (Sobs index, = 0.019; Chao1 index, = 0.033). Sobs and Chao1 indices were also lower in patients with BBLs than healthy individuals, without statistical significance ( = 0.279, = 0.314, respectively). Both unweighted and weighted UniFrac analysis showed that beta diversity differed significantly among the three groups ( = 3.376e-14, < 0.001, respectively). Compared with healthy individuals, the levels of and were higher in BC patients ( = 0.004, = 0.007, respectively), whereas and were more enriched in the benign breast lesion group ( < 0.001, = 0.011, respectively). Our study indicates that patients with BC and BBLs may undergo significant changes in intestinal microbiota. These findings can help elucidate the role of intestinal flora in BC and BBLs patients.

摘要

乳腺癌 (BC) 和良性乳腺病变 (BBL) 是全球女性常见的疾病。肠道微生物群在调节乳腺疾病的发生、发展和治疗反应方面起着至关重要的作用。因此,我们探索了 BC 和 BBL 患者肠道微生物群的结构和功能。本研究纳入了 66 名受试者。26 名受试者患有 BC,20 名受试者患有 BBL,20 名匹配的健康对照。采用高通量 16S 核糖体 RNA (16S rRNA) 基因测序技术确定微生物群落结构。与健康个体相比,BC 患者的 alpha 多样性指数 (Sobs 指数, = 0.019;Chao1 指数, = 0.033) 显著降低。BBL 患者的 Sobs 和 Chao1 指数也低于健康个体,但无统计学意义 ( = 0.279, = 0.314)。未加权和加权 UniFrac 分析均显示三组间 beta 多样性差异显著 ( = 3.376e-14, < 0.001)。与健康个体相比,BC 患者的 和 水平更高 ( = 0.004, = 0.007),而良性乳腺病变组中 和 更为丰富 ( < 0.001, = 0.011)。本研究表明,BC 和 BBL 患者的肠道微生物群可能发生显著变化。这些发现有助于阐明肠道菌群在 BC 和 BBL 患者中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/5c57e09562dc/pjm-71-217-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/5a854f960e98/pjm-71-217-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/00c0c4550c06/pjm-71-217-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/ebcc90b32027/pjm-71-217-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/cb8d8158423d/pjm-71-217-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/efbc43c40bb1/pjm-71-217-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/e4e6b66417ed/pjm-71-217-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/5c57e09562dc/pjm-71-217-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/5a854f960e98/pjm-71-217-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/00c0c4550c06/pjm-71-217-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/ebcc90b32027/pjm-71-217-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/cb8d8158423d/pjm-71-217-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/efbc43c40bb1/pjm-71-217-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/e4e6b66417ed/pjm-71-217-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13a/9252143/5c57e09562dc/pjm-71-217-g006.jpg

相似文献

1
Analysis of Gut Microbiota in Patients with Breast Cancer and Benign Breast Lesions.乳腺癌与良性乳腺病变患者的肠道菌群分析。
Pol J Microbiol. 2022 May 31;71(2):217-226. doi: 10.33073/pjm-2022-019.
2
[Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].[16S核糖体RNA高通量测序技术分析特重度烧伤患者肠道微生物群的动态变化]
Zhonghua Shao Shang Za Zhi. 2020 Dec 20;36(12):1159-1166. doi: 10.3760/cma.j.cn501120-20200518-00271.
3
Changes in the fecal microbiota of breast cancer patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis.基于 16S rRNA 基因测序的乳腺癌患者粪便微生物组变化:系统评价和荟萃分析。
Clin Transl Oncol. 2024 Jun;26(6):1480-1496. doi: 10.1007/s12094-023-03373-5. Epub 2024 Jan 13.
4
Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing.使用 16SrRNA 测序研究微生物组与结直肠癌易感性的关系。
Biomed Res Int. 2020 Jan 30;2020:7828392. doi: 10.1155/2020/7828392. eCollection 2020.
5
Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.基于粪便代谢组学联合 16S rRNA 基因测序分析肾阳虚证大鼠肠道菌群变化及右归丸的干预作用
J Ethnopharmacol. 2019 Nov 15;244:112139. doi: 10.1016/j.jep.2019.112139. Epub 2019 Aug 8.
6
Identifying distinctive tissue and fecal microbial signatures and the tumor-promoting effects of deoxycholic acid on breast cancer.鉴定有区别的组织和粪便微生物特征以及脱氧胆酸对乳腺癌的促瘤作用。
Front Cell Infect Microbiol. 2022 Dec 13;12:1029905. doi: 10.3389/fcimb.2022.1029905. eCollection 2022.
7
Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma.生长激素型垂体腺瘤患者的肠道菌群特征。
Microbiol Spectr. 2022 Feb 23;10(1):e0042521. doi: 10.1128/spectrum.00425-21. Epub 2022 Jan 12.
8
Faecal Microbiota Composition Varies between Patients with Breast Cancer and Healthy Women: A Comparative Case-Control Study.粪便微生物组成在乳腺癌患者和健康女性之间存在差异:一项病例对照比较研究。
Nutrients. 2021 Aug 5;13(8):2705. doi: 10.3390/nu13082705.
9
Phenylketonuria Diet Promotes Shifts in Firmicutes Populations.苯丙酮尿症饮食促进厚壁菌门种群的转变。
Front Cell Infect Microbiol. 2019 Apr 16;9:101. doi: 10.3389/fcimb.2019.00101. eCollection 2019.
10
Gut Microbiota Predict Expansion but Not Vancomycin-Resistant Acquisition.肠道微生物群可预测扩张,但不能预测万古霉素耐药性的获得。
mSphere. 2020 Nov 18;5(6):e00537-20. doi: 10.1128/mSphere.00537-20.

引用本文的文献

1
Breast cancer and microbiome: a systematic review highlighting challenges for clinical translation.乳腺癌与微生物群:一项强调临床转化挑战的系统综述
BMC Womens Health. 2025 Aug 30;25(1):416. doi: 10.1186/s12905-025-03843-8.
2
Effects of alcohol on gut microbiome in adolescent and adult MMTV-Wnt1 mice.酒精对青春期和成年MMTV-Wnt1小鼠肠道微生物群的影响。
Front Oncol. 2025 Jul 16;15:1557040. doi: 10.3389/fonc.2025.1557040. eCollection 2025.
3
The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications.

本文引用的文献

1
The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer.肿瘤发生和细菌代谢产物信号在乳腺癌转移形成中的作用。
Cancer Metastasis Rev. 2021 Dec;40(4):1223-1249. doi: 10.1007/s10555-021-10013-3. Epub 2021 Dec 30.
2
Comparison of the Gut Microbiota in Patients with Benign and Malignant Breast Tumors: A Pilot Study.良性和恶性乳腺肿瘤患者肠道微生物群的比较:一项初步研究。
Evol Bioinform Online. 2021 Nov 13;17:11769343211057573. doi: 10.1177/11769343211057573. eCollection 2021.
3
Faecal Microbiota Composition Varies between Patients with Breast Cancer and Healthy Women: A Comparative Case-Control Study.
肠道微生物群及其在癌症代谢、发生和进展中的多方面作用:见解与治疗意义
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251331960. doi: 10.1177/15330338251331960. Epub 2025 Apr 10.
4
The estrobolome: Estrogen-metabolizing pathways of the gut microbiome and their relation to breast cancer.雌激素代谢菌丛:肠道微生物群的雌激素代谢途径及其与乳腺癌的关系
Int J Cancer. 2025 Apr 3. doi: 10.1002/ijc.35427.
5
The gut microbiota during tamoxifen therapy in patients with breast cancer.乳腺癌患者他莫昔芬治疗期间的肠道微生物群
Sci Rep. 2025 Mar 6;15(1):7874. doi: 10.1038/s41598-025-91734-1.
6
Interactions between the tumor microbiota and breast cancer.肿瘤微生物群与乳腺癌之间的相互作用。
Front Cell Infect Microbiol. 2025 Jan 24;14:1499203. doi: 10.3389/fcimb.2024.1499203. eCollection 2024.
7
Intratumoral in Breast Cancer: Unraveling the Interplay with Hormone Receptors and Impact on Tumor Immunity.乳腺癌瘤内情况:解析与激素受体的相互作用及对肿瘤免疫的影响
Int J Biol Sci. 2025 Jan 6;21(3):974-988. doi: 10.7150/ijbs.98260. eCollection 2025.
8
Gut microbiota interact with breast cancer therapeutics to modulate efficacy.肠道微生物群与乳腺癌治疗药物相互作用以调节疗效。
EMBO Mol Med. 2025 Feb;17(2):219-234. doi: 10.1038/s44321-024-00185-0. Epub 2025 Jan 16.
9
Metabolites in the Dance: Deciphering Gut-Microbiota-Mediated Metabolic Reprogramming of the Breast Tumor Microenvironment.舞动中的代谢物:解读肠道微生物群介导的乳腺肿瘤微环境代谢重编程
Cancers (Basel). 2024 Dec 11;16(24):4132. doi: 10.3390/cancers16244132.
10
Exploring the relationship between gut microbiota and breast diseases using Mendelian randomization analysis.使用孟德尔随机化分析探索肠道微生物群与乳腺疾病之间的关系。
Front Med (Lausanne). 2024 Nov 26;11:1450298. doi: 10.3389/fmed.2024.1450298. eCollection 2024.
粪便微生物组成在乳腺癌患者和健康女性之间存在差异:一项病例对照比较研究。
Nutrients. 2021 Aug 5;13(8):2705. doi: 10.3390/nu13082705.
4
Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden.瑞典女性良性乳腺疾病的特征及其与年龄、激素因素和乳腺癌家族史的关系。
JAMA Netw Open. 2021 Jun 1;4(6):e2114716. doi: 10.1001/jamanetworkopen.2021.14716.
5
Multifaceted modes of action of the anticancer probiotic Enterococcus hirae.抗癌益生菌肠球菌的多效作用模式。
Cell Death Differ. 2021 Jul;28(7):2276-2295. doi: 10.1038/s41418-021-00753-8. Epub 2021 May 11.
6
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment.肠道微生物群影响早期乳腺癌治疗的临床结局和副作用。
Cell Death Differ. 2021 Sep;28(9):2778-2796. doi: 10.1038/s41418-021-00784-1. Epub 2021 May 7.
7
A Newly Characterized Potentially Probiotic Strain, Lactobacillus brevis MK05, and the Toxicity Effects of its Secretory Proteins Against MCF-7 Breast Cancer Cells.一株新型潜在益生菌短乳杆菌 MK05 及其分泌蛋白对 MCF-7 乳腺癌细胞的毒性作用。
Probiotics Antimicrob Proteins. 2021 Aug;13(4):982-992. doi: 10.1007/s12602-021-09766-8. Epub 2021 Mar 9.
8
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer.肠道微生物群条件性影响曲妥珠单抗治疗 HER2 阳性乳腺癌的疗效。
Cancer Res. 2021 Apr 15;81(8):2195-2206. doi: 10.1158/0008-5472.CAN-20-1659. Epub 2021 Jan 22.
9
Milk fermented by Lactobacillus casei CRL431 administered as an immune adjuvant in models of breast cancer and metastasis under chemotherapy.干酪乳杆菌CRL431发酵的牛奶在化疗条件下的乳腺癌和转移模型中作为免疫佐剂使用。
Appl Microbiol Biotechnol. 2021 Jan;105(1):327-340. doi: 10.1007/s00253-020-11007-x. Epub 2020 Nov 18.
10
The effect of Poria cocos ethanol extract on the intestinal barrier function and intestinal microbiota in mice with breast cancer.茯苓乙醇提取物对乳腺癌小鼠肠道屏障功能和肠道微生物群的影响。
J Ethnopharmacol. 2021 Feb 10;266:113456. doi: 10.1016/j.jep.2020.113456. Epub 2020 Oct 8.